Graham NM - Search Results

1

CD4+ lymphocyte response to zidovudine as a predictor of AIDS-free time and survival time.

Graham NM, Piantadosi S, Park LP, Phair JP, Rinaldo CR, Fahey JL. Graham NM, et al. J Acquir Immune Defic Syndr (1988). 1993 Nov;6(11):1258-66. J Acquir Immune Defic Syndr (1988). 1993. PMID: 7901384

2

Early versus deferred zidovudine monotherapy: impact on AIDS-free time and survival in the multicenter AIDS cohort study.

Detels R, Muñoz A, Peng Y, Graham N, Mellors J, Phair J. Detels R, et al. Antivir Ther. 1997 Jan;2(1):21-9. Antivir Ther. 1997. PMID: 11322263 Clinical Trial.

3

The effects on survival of early treatment of human immunodeficiency virus infection.

Graham NM, Zeger SL, Park LP, Vermund SH, Detels R, Rinaldo CR, Phair JP. Graham NM, et al. N Engl J Med. 1992 Apr 16;326(16):1037-42. doi: 10.1056/NEJM199204163261601. N Engl J Med. 1992. PMID: 1347907 Free article. Clinical Trial.

4

Effect of CD4+ cell count measurement variability on staging HIV-1 infection.

Hoover DR, Graham NM, Chen B, Taylor JM, Phair J, Zhou SY, Muñoz A. Hoover DR, et al. Among authors: graham nm. J Acquir Immune Defic Syndr (1988). 1992;5(8):794-802. J Acquir Immune Defic Syndr (1988). 1992. PMID: 1355556

5

Zidovudine use in AIDS-free HIV-1-seropositive homosexual men in the Multicenter AIDS Cohort Study (MACS), 1987-1989.

Graham NM, Zeger SL, Kuo V, Jacobson LP, Vermund SH, Phair JP, Detels R, Rinaldo CR, Saah AJ. Graham NM, et al. J Acquir Immune Defic Syndr (1988). 1991;4(3):267-76. J Acquir Immune Defic Syndr (1988). 1991. PMID: 1671411

6

Effect of zidovudine and Pneumocystis carinii pneumonia prophylaxis on progression of HIV-1 infection to AIDS. The Multicenter AIDS Cohort Study.

Graham NM, Zeger SL, Park LP, Phair JP, Detels R, Vermund SH, Ho M, Saah AJ. Graham NM, et al. Lancet. 1991 Aug 3;338(8762):265-9. doi: 10.1016/0140-6736(91)90414-k. Lancet. 1991. PMID: 1677108 Free article. Clinical Trial.

7

Long-term survival without clinical AIDS after CD4+ cell counts fall below 200 x 10(6)/l.

Hoover DR, Rinaldo C, He Y, Phair J, Fahey J, Graham NM. Hoover DR, et al. Among authors: graham nm. AIDS. 1995 Feb;9(2):145-52. AIDS. 1995. PMID: 7718184

8

Prognostic value of combined response markers among human immunodeficiency virus-infected persons: possible aid in the decision to change zidovudine monotherapy.

Graham NM, Park LP, Piantadosi S, Phair JP, Mellors J, Fahey JL, Saah AJ. Graham NM, et al. Clin Infect Dis. 1995 Feb;20(2):352-62. doi: 10.1093/clinids/20.2.352. Clin Infect Dis. 1995. PMID: 7742442

9

The effect of the interaction of acyclovir with zidovudine on progression to AIDS and survival. Analysis of data in the Multicenter AIDS Cohort Study.

Stein DS, Graham NM, Park LP, Hoover DR, Phair JP, Detels R, Ho M, Saah AJ. Stein DS, et al. Among authors: graham nm. Ann Intern Med. 1994 Jul 15;121(2):100-8. doi: 10.7326/0003-4819-121-2-199407150-00004. Ann Intern Med. 1994. PMID: 8017721 Clinical Trial.

10

Clinical factors associated with weight loss related to infection with human immunodeficiency virus type 1 in the Multicenter AIDS Cohort Study.

Graham NM, Muñoz A, Bacellar H, Kingsley LA, Visscher BR, Phair JP. Graham NM, et al. Am J Epidemiol. 1993 Feb 15;137(4):439-46. doi: 10.1093/oxfordjournals.aje.a116692. Am J Epidemiol. 1993. PMID: 8096357

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

210 results

Search Page

Filters